IMU 4.00% 4.8¢ imugene limited

Ann: Clinical Trial of New Cancer Oncolytic Virotherapy Vaxinia, page-23

  1. 2,888 Posts.
    lightbulb Created with Sketch. 12290
    Yes - very good to see this.

    Imugene has a deeply impressive - in fact quite astonishing - program of clinical trials either in progress or scheduled to start soon. Now the Vaxinia trial also launches as per the plan.

    This like watching an enormous wave build - with the mass, the momentum and the wave height increasing steadily while we watch.

    It is unlikely that every trial will succeed - science seldom works like that - but every single trial does have very solid pre-clinical data indicating a fair probability of success.

    If/when positive clinical trial results start to come out - the wave will break and Imugene shareholders will be on a wild ride.

    Cheers

    Dave

 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.